Moreover, the release of CXCL8 from PTEN-depleted prostate cancer cells may act in a paracrine manner to increase the expression and secretion of CCL2 and CXCL12 from neighboring stromal cells. This evidence concerns the gene CCL2 and prostate carcinoma.